Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Liver International : Official Journal of the International Association for the Study of the Liver|June 27, 2024
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trialEnrico Pompili, Maurizio Baldassarre, Giulia Iannone, et al.European Journal of Clinical Pharmacology|July 24, 2010
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitisGaetano Bertino, Annalisa Ardiri, Patrizia Maria Boemi, et al.Free Radical Research|June 7, 2006
Oxidative stress, nitric oxide, endothelial dysfunction and tinnitusSergio Neri, Santo Signorelli, Davide Pulvirenti, et al.Journal of Clinical Gastroenterology|September 15, 2010
A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirinSergio Neri, Gaetano Bertino, Antonio Petralia, et al.United European Gastroenterology Journal|July 11, 2026
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and AscitesEnrico Pompili, Giacomo Zaccherini, Silvia Nardelli, et al.Orphanet Journal of Rare Diseases|March 12, 2015
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyAndrea Zanichelli, Francesco Arcoleo, Maria Pina Barca, et al.Journal of Hepatology|August 28, 2020
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascitesPaolo Caraceni, Manuel Tufoni, Giacomo Zaccherini, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 18, 2019
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema AttacksTimothy Craig, Bruce Zuraw, Hilary Longhurst, et al.Lancet (London, England)|June 5, 2018
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trialPaolo Caraceni, Oliviero Riggio, Paolo Angeli, et al.The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.Pageof 4